ALLURION

Allurion is dedicated to ending obesity. The Allurion Balloon is the world's first weight-loss balloon that does not routinely require surgery, endoscopy or anesthesia for placement or removal. It is backed by a full package of support for both patients and clinicians. The Allurion Program features the Allurion gastric balloon, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for clinicians, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan. Patients on the Allurion Program lose an average of 10-15% of their total body weight in 4 months. The Allurion Balloon is not currently approved in the United States... At Allurion, we seek to end obesity globally, helping our patients to live fuller, longer lives. We aim to be the..

Also known as: Allurion France S.A.S., Allurion Technologies, Allurion Technologies Inc.

Primary location: Paris France